Catalyst Wire Dossier Catalyst Wire Dossier

TRI476

oxcarbazepine · Nobelpharma
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TRI476, covering 2019-11-15 to 2019-11-15. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures [Phase 2, Phase 3]

See pricing